JP2007504273A5 - - Google Patents

Download PDF

Info

Publication number
JP2007504273A5
JP2007504273A5 JP2006529506A JP2006529506A JP2007504273A5 JP 2007504273 A5 JP2007504273 A5 JP 2007504273A5 JP 2006529506 A JP2006529506 A JP 2006529506A JP 2006529506 A JP2006529506 A JP 2006529506A JP 2007504273 A5 JP2007504273 A5 JP 2007504273A5
Authority
JP
Japan
Prior art keywords
sdf
adhesions
inhibitor
adhesion
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006529506A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007504273A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2004/000800 external-priority patent/WO2004105737A2/en
Publication of JP2007504273A publication Critical patent/JP2007504273A/ja
Publication of JP2007504273A5 publication Critical patent/JP2007504273A5/ja
Withdrawn legal-status Critical Current

Links

JP2006529506A 2003-05-30 2004-05-28 種々の作用剤を用いた、線維性癒着の抑制に関する医薬組成物及び方法 Withdrawn JP2007504273A (ja)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US47490703P 2003-05-30 2003-05-30
US47765403P 2003-06-10 2003-06-10
US50525803P 2003-09-22 2003-09-22
US50525703P 2003-09-22 2003-09-22
US52080403P 2003-11-17 2003-11-17
US52057403P 2003-11-17 2003-11-17
US52080803P 2003-11-17 2003-11-17
US52913603P 2003-12-11 2003-12-11
US53366903P 2003-12-31 2003-12-31
PCT/CA2004/000800 WO2004105737A2 (en) 2003-05-30 2004-05-28 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents

Publications (2)

Publication Number Publication Date
JP2007504273A JP2007504273A (ja) 2007-03-01
JP2007504273A5 true JP2007504273A5 (https=) 2007-07-19

Family

ID=33494425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006529506A Withdrawn JP2007504273A (ja) 2003-05-30 2004-05-28 種々の作用剤を用いた、線維性癒着の抑制に関する医薬組成物及び方法

Country Status (8)

Country Link
EP (1) EP1631265A2 (https=)
JP (1) JP2007504273A (https=)
KR (1) KR20060034227A (https=)
AU (1) AU2004243513A1 (https=)
BR (1) BRPI0418384A (https=)
CA (1) CA2527429A1 (https=)
TW (1) TW200509949A (https=)
WO (1) WO2004105737A2 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2729826T3 (es) * 2004-09-23 2019-11-06 Arc Medical Devices Inc Composiciones farmacéuticas y métodos relacionados para inhibir adherencias fibrosas o enfermedad inflamatoria usando fucanos con bajo contenido de sulfato
CA2606081C (en) 2005-04-26 2013-09-17 Markus M. Heiss Combination of the application of antibodies for immunostimulation together with glucocorticoids
AU2006244393B2 (en) * 2005-05-05 2012-06-21 Cook Biotech Incorporated Implantable materials and methods for inhibiting tissue adhesion formation
DE102005023170A1 (de) * 2005-05-19 2006-11-23 Curevac Gmbh Optimierte Formulierung für mRNA
US8426381B2 (en) 2005-09-09 2013-04-23 Lucas Meyer Cosmetics Canada Inc. Polysaccharides compositions comprising fucans and galactans and their use to reduce extravasation and inflammation
DE102008005172A1 (de) * 2008-01-19 2009-07-23 Mike Ehrlich Pharmazeutische Zusammensetzung zur Verhinderung von post-operativen Adhäsionen
WO2009103808A2 (en) * 2008-02-20 2009-08-27 Devgen N.V. Methods and compositions for increasing rna interference
US8440237B2 (en) 2009-04-27 2013-05-14 Mary Kay Inc. Botanical anti-acne formulations
JO3676B1 (ar) * 2009-07-27 2020-08-27 Arc Medical Devices Inc مركبات صيدلانية تضم فوكانات معدلة وطرق تتعلق بها
EA027666B1 (ru) 2010-05-03 2017-08-31 ТЕИКОКУ ФАРМА ЮСЭй, ИНК. Неводные лекарственные средства в форме проэмульсии на основе таксанов и способы их приготовления и использования
TWI382841B (zh) 2010-10-29 2013-01-21 Univ China Medical 用於抑制發炎之醫藥組合物
US8936635B2 (en) 2011-03-23 2015-01-20 Palmetto Pharmaceuticals Llc Bioresorbable nitric oxide agonist prodrug scaffolds for vascular stents
US20130095160A1 (en) * 2011-09-12 2013-04-18 Gautam S. GHATNEKAR Resorbable polystatin biomaterials
EP3566691B1 (en) 2011-12-19 2024-04-17 Mary Kay Inc. Cosmetic method of whitening skin and evening tone with azuki beans
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
US9421221B2 (en) 2012-11-12 2016-08-23 Warsaw Orthopedic, Inc. Compositions and methods for inhibiting adhesion formation
US9474767B2 (en) 2012-11-12 2016-10-25 Warsaw Orthopedic, Inc. Compositions and methods for inhibiting bone growth
US9707323B2 (en) 2012-11-12 2017-07-18 Warsaw Orthopedic, Inc. Devices and methods for inhibiting adhesion formation
ITTO20130317A1 (it) * 2013-04-19 2014-10-20 Idea Medical Devices S R L Dispositivo medico comprendente una struttura di supporto a base di chitosano
CN103267842B (zh) * 2013-05-15 2016-03-02 郭杰标 检测中成药违法添加双氯芬酸的免疫胶体金方法
JP6367188B2 (ja) 2013-05-29 2018-08-01 株式会社大塚製薬工場 癒着防止材
US9566296B2 (en) 2013-11-08 2017-02-14 Warsaw Orthopedic, Inc. Multi-layered anti-adhesion device
US9849077B2 (en) 2014-03-10 2017-12-26 Mary Kay Inc. Skin lightening compositions
US12186334B2 (en) 2018-07-27 2025-01-07 ARC Medical Inc. High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
BR112021000617A2 (pt) 2018-07-27 2021-04-06 Arc Medical Devices Inc. Fucanos com elevado teor de sulfato para o tratamento de aderências fibrosas
MX2021000866A (es) 2019-03-05 2021-06-15 Arc Medical Devices Inc Sistemas y metodos para la filtracion de flujo tangencial de composiciones viscosas.
KR20250011204A (ko) * 2022-05-30 2025-01-21 시노허브 파마슈티컬 씨오., 엘티디 유착 관련 질환을 예방 치료하는 약물의 제조에서 테트라히드로나프티리딘 유도체의 응용

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57167919A (en) * 1981-04-07 1982-10-16 Hirozo Ohira Preventing agent for intraperitoneal adhesion
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5266326A (en) * 1992-06-30 1993-11-30 Pfizer Hospital Products Group, Inc. In situ modification of alginate
US6150581A (en) * 1995-06-07 2000-11-21 United States Surgical Corporation Chitosan/alginate anti-adhesion barrier
KR20010010151A (ko) * 1999-07-16 2001-02-05 김윤 수용성 알긴산염과 카르복시메틸 셀룰로오스를 주성분으로 하는 유착방지제 및 그의 제조방법
KR20010107067A (ko) * 2000-05-25 2001-12-07 김정식 유착방지제
US6812220B2 (en) * 2001-08-29 2004-11-02 University Of British Columbia Pharmaceutical compositions and methods relating to fucans
KR100523953B1 (ko) * 2002-08-27 2005-10-25 주식회사 엘지생명과학 천연다당류와 히알루론산의 마이크로비드 및 이의 제조 방법

Similar Documents

Publication Publication Date Title
CA2623471C (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
JP2007504273A5 (https=)
JP2007504273A (ja) 種々の作用剤を用いた、線維性癒着の抑制に関する医薬組成物及び方法
AU2002325113B2 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
AU2002325113A1 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
CN102665733B (zh) 用于治疗纤维性粘连和其它疾病的包含改性岩藻多糖的药物组合物
US20070238697A1 (en) Pharmaceutical compositions and methods relating to fucans
CN1829501A (zh) 涉及使用多种药物抑制纤维粘连的药用组合物和方法
US20170252367A1 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
AU2007200318B2 (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
HK1094949A (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
HK1108566A (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis
HK1066482B (en) Use of fucans in the treatment of adhesions, arthritis and psoriasis